Heart output measurement in shock patients on life support
Part of Heart & circulation clinical trials.
This study tests if a new way of measuring heart function (using sound waves and breath analysis) works well in patients who are in severe heart failure and need a heart-lung machine. It might help doctors better monitor patients after heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had heart surgery and need a heart-lung machine for support
- You or your family agree to take part in the study
- You are not pregnant or breastfeeding
- You are not expected to live less than 3 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device that helps support your heart when it's in cardiogenic shock (a life-threatening condition where the heart can't pump enough blood). The device works alongside standard treatments to improve blood flow and reduce strain on the heart.
This study tests a special monitoring approach (likely using an implanted device) to help prevent serious complications after you survive cardiogenic shock in the hospital. It may help the care team detect problems earlier so treatments can start sooner.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This study measures pressures inside the heart during cardiac surgery to better understand how well the heart is working. It may help doctors improve care for patients having certain heart valve or aorta procedures.
This study tests a device that helps the heart pump blood when it is too weak to do so, even with medicine, after surgery, or while waiting for a transplant. It aims to see if it's safe and works well.
This study uses ultrasound to measure how much blood the heart pumps in patients with septic shock, a severe infection that causes dangerously low blood pressure. It may help doctors better understand and manage this condition.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.